NFKB1 and posterior cortical atrophy: When combined with docetaxel (the primary chemotherapeutic agent for advanced PCa), roburic acid leads to the suppression of NF-kB and Bcl2 (in the intrinsic apoptosis pathway), along with an upregulation of Bax (apoptosis regulator Bax).